Concepedia

Publication | Closed Access

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

DOI

653

Citations

18

References

1998

Year

Soonmyung Paik, John Bryant, Chanheun Park, Bernard Fisher, Elizabeth Tan-Chiu, David M. Hyams, Edwin R. Fisher, Marc E. Lippman, D. Lawrence Wickerham, Norman Wolmark
JNCI Journal of the National Cancer Institute

Abstract

These data support the hypothesis of a preferential benefit from doxorubicin in patients with erbB-2-positive breast cancer.

References

YearCitations

Page 1